Source: International Congress 2017 – The latest in lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
Rainer Wiewrodt (Münster, Germany). Solid, liquid or volatile? What is the latest issue when diagnosing suspicious tissue in thoracic oncology?. International Congress 2017 – The latest in lung cancer

Member's Comments

No comment yet.

Related content which might interest you: Conventional cytology vs liquid based cytology in preparation of bronchial wash, does the later have potential advantages? Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Management of incidental nodules in lung cancer screening: ready for prime-time? Source: Breathe, 15 (4) 346; 10.1183/20734735.0247-2019 Year: 2019 Clinical nurse specialist led image guided pleural interventions – Is it safe? Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 Should CT-guided biopsy for suspected lung cancer be delayed pending PET/CT results? Source: International Congress 2016 – Transbronchial diagnostics: from ILD to pheripheral lesions Year: 2016 Improving tumour documentation in thoracic oncology: what can we learn from each other? Source: Annual Congress 2012 - Good quality clinical recommendations for thoracic malignancy management in Europe Year: 2012 Late Breaking Abstract - High diagnostic yield of ultrasound-assisted percutaneous biopsies of peripheral lung, pleural and subcutaneous lesions performed by respiratory physicians Source: International Congress 2019 – Interventional pulmonology techniques: targeting selective lung tissue Year: 2019 Lung nodule management in Covid-19;does postponed surveillance matter? Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 Is time from "referral to diagnosis" in lung cancer pathway affected by diagnostic test delays? Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Endoscopic management of benign tracheobronchial tumors: Ten-year experience from a large, single center case series Source: Annual Congress 2013 –Therapeutical bronchoscopy for treatment of airway disorders: laser, stents and more Year: 2013 Safety of a new "all in one" 3D device for fiducial tumor marking: A pilot animal study Source: International Congress 2016 – Transbronchial diagnostics: from ILD to pheripheral lesions Year: 2016 EBUS in real life: Primary diagnosis and mediastinal staging Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Profile and nodule characteristics of patients with incidental solid pulmonary nodules Source: International Congress 2016 – A view into a chest and pleural pathology Year: 2016 Synchronous primary lung cancers;a clinical challenge in modern thoracic oncology Source: International Congress 2018 – Thoracic surgery, pleural effusions and other general thoracic surgery Year: 2018 Pneumothoraces in CT guided lung biopsies – Are we too cautious? Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016 In the era of personalised medicine, is pleural fluid cytology sufficient for oncological treatment? Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018 Immunotherapy: a new standard of care in thoracic malignancies? Source: Eur Respir J, 51 (2) 1702072; 10.1183/13993003.02072-2017 Year: 2018 Volatile organic compounds in exhaled breath samples as potential biomarkers in early diagnosis of lung cancer – (Ege translational pulmonology research group [EgeTPAG]) Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Combined endosonographic staging followed by cervical mediastinoscopy in the real world, do we still need both? Source: Annual Congress 2012 - EBUS-TBNA: a never ending story Year: 2012